A Flu Season Like No Other: Europe's Battle Against a Mutated Strain
As the NHS prepares for an unprecedented surge in flu cases, a question looms: is this strain also wreaking havoc across continental Europe? With mutations potentially fueling faster and more widespread infections, the effectiveness of vaccines is under scrutiny.
The NHS is gearing up for a winter crisis, with flu cases overwhelming healthcare services. Meanwhile, continental Europe is also grappling with a flu season that started earlier than usual, and the same strain is causing concern.
When Does Flu Season Begin?
In the northern hemisphere, flu season typically runs from November to February, but this year, it started as early as October. Health officials declare the season's onset when 10% of suspected cases test positive for flu. In England, this threshold was crossed in early November, indicating a significant shift from the previous year.
The Cause of This Year's Outbreak: A Mutated Strain
Flu is caused by various influenza viruses, with influenza A and B being the main culprits. Within influenza A, H1N1 and H3N2 are common subtypes. In the UK, a particular H3N2 strain, descended from Australia's record-breaking flu season, is dominating. This strain has acquired seven new mutations, creating a 'drifted' H3N2 subclade K, which is believed to spread more rapidly.
Europe's Flu Landscape: A Mixed Picture
While the situation mirrors the UK in some countries, others are faring worse. Europe's flu season began three to four weeks early, but the drifted H3N2 strain emerged as the primary cause of infections only recently in certain regions. Germany's Robert Koch Institute reports an early start to the season, with a clear increase in H3N2 cases over the past three weeks. In France, the season began a week earlier than usual, with H1N1 and H3N2 subclade K cases detected in equal numbers.
France's public health agency, Sante publique, warns of a strong increase in flu activity across metropolitan France, affecting all age groups. Hospital admissions and emergency department visits have risen, with Corsica being the only region with lower case numbers.
Spain, Romania, Hungary, and Ireland are also experiencing surges in flu cases, with hospitalisations on the rise.
Vaccine Effectiveness: A Complex Picture
The mutations in the drifted H3N2 strain mean it is not well-recognized by the immune system, leading to reduced vaccine effectiveness. Data from the UK's Health Security Agency confirms that vaccines are less effective against this strain, but they still provide protection against severe disease. Early data shows vaccine protection against hospital attendance and admission is within the normal range for flu vaccines.
Despite the reduced effectiveness, health officials strongly advocate for vaccination to reduce the risk of severe illness. In France, nearly eight million people have already received the flu vaccine, a significant increase from last year.
Data from Sante publique highlights the importance of vaccination, with most intensive care patients over 65 and having pre-existing medical conditions, and nearly all of them unvaccinated.
And Here's Where It Gets Controversial...
With the vaccine's effectiveness being lower than hoped, some may question the value of getting vaccinated. However, health officials emphasize the benefits of reduced severe illness and hospitalization. What do you think? Should we focus more on personal responsibility and individual choices when it comes to vaccination? Share your thoughts in the comments!
